Stefan Kurpig

Sigmund Freud Str. 25
Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN).

Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN).

Journal: European journal of nuclear medicine and molecular imaging

Published: May 14, 2025

Diagnosis of periprosthetic loosening of total hip and knee arthroplasty using 68Gallium-Zoledronate PET/CT.

Diagnosis of periprosthetic loosening of total hip and knee arthroplasty using 68Gallium-Zoledronate PET/CT.

Journal: Archives of orthopaedic and trauma surgery

Published: April 17, 2024

Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options.

Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options.

Journal: Cancers

Published: December 28, 2022

Radiolabeling Strategies of Nanobodies for Imaging Applications.

Radiolabeling Strategies of Nanobodies for Imaging Applications.

Journal: Diagnostics (Basel, Switzerland)

Published: July 01, 2021

Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga-PSMA uptake in LNCaP cells.

Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga-PSMA uptake in LNCaP cells.

Journal: Journal of cancer research and clinical oncology

Published: September 07, 2020

DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis-Challenges and Critical Points in Implementation into Clinical Routine.

DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis-Challenges and Critical Points in Implementation into Clinical Routine.

Journal: Molecules (Basel, Switzerland)

Published: June 11, 2020

[177Lu]Lu-DOTA-zoledronate therapy - first application in a patient with primary osseous metastatic bronchial carcinoma.

[177Lu]Lu-DOTA-zoledronate therapy - first application in a patient with primary osseous metastatic bronchial carcinoma.

Journal: Nuklearmedizin. Nuclear medicine

Published: April 29, 2020

Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results.

Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results.

Journal: EJNMMI research

Published: June 06, 2019

Ethanol effects on 68Ga-radiolabelling efficacy and radiolysis in automated synthesis utilizing NaCl post-processing.

Ethanol effects on 68Ga-radiolabelling efficacy and radiolysis in automated synthesis utilizing NaCl post-processing.

Journal: EJNMMI radiopharmacy and chemistry

Published: May 30, 2019

Manual vs automated 68 Ga-radiolabelling-A comparison of optimized processes.

Manual vs automated 68 Ga-radiolabelling-A comparison of optimized processes.

Journal: Journal of labelled compounds & radiopharmaceuticals

Published: May 28, 2019

Radionuclide intake risks in the clinical administration of 223RaCl2.

Radionuclide intake risks in the clinical administration of 223RaCl2.

Journal: Journal of radiological protection : official journal of the Society for Radiological Protection

Published: February 05, 2019

Preliminary results of biodistribution and dosimetric analysis of [68Ga]Ga-DOTAZOL: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases.

Preliminary results of biodistribution and dosimetric analysis of [68Ga]Ga-DOTAZOL: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases.

Journal: Annals of nuclear medicine

Published: December 27, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026